HRP Streptavidin

Pricing & Availability
Regulatory Status
RUO
Other Names
Streptavidin-Horseradish Peroxidase, SAv-HRP
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
405210 1 mL 97€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Streptavidin binds to biotin with high affinity. Streptavidin-HRP is useful for detecting biotinylated antibodies, e.g., in ELISA, ELISPOT, IHC or Western blotting. For ELISA applications, HRP will act on soluble substrates, such as ABTS or TMB, to yield a colorimetric reaction. For ELISPOT or Western blotting applications, HRP will act on precipitating substrates, such as 4CN, to yield a colorimetric reaction.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Human, Mouse, Rat, All Species
Formulation
Buffered solution containing bovine protein and preservatives (methylisothiazolone, bromonitrodioxane, and other active isothiazolones).
Preparation
Streptavidin is conjugated with horseradish peroxidase under optimal conditions.
Storage & Handling
The streptavidin-HRP solution should be stored undiluted between 2°C and 8°C. Avoid exposure to sodium azide.

This product has a shelf-life of 12 months or less. Please use our Expiration Lookup Tool to verify the expiration date of your lot of product
Application

ELISA - Quality tested
ELISPOT, WB, IHC - Reported in the literature, not verified in house

Recommended Usage

Each lot of this Streptavidin-HRP is quality control tested by ELISA assay. For ELISA or Western blot analysis, the reagent should be titrated between 1:1000 - 1:3000 to determine optimal conditions. For ELISPOT analysis, the reagent should be titrated between 1:500 - 1:1500 to determine optimal conditions. Avoid using biotin-containing solutions as diluents and solutions containing sodium azide. Sodium azide is an inhibitor of horseradish peroxidase. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Streptavidin-HRP is useful as a second step reagent for indirect enzymatic labelling, in conjunction with biotinylated primary antibodies. Sav-HRP is recommended for ELISA, ELISPOT and Western blotting, when used with the relevant substrate system.

Application References
  1. Li KJ, et al. 2006. J. Leukoc. Biol. doi:10.1189/jlb.1105668.PubMed
  2. Weldon S, et al. 2009. J. Immunol. 183:8148. PubMed
  3. Basnayake K, et al. 2010. J Am Soc Naphrol. 21:1165. PubMed
  4. Marder W, et al. 2011. Ann Rheum Dis. PubMed
  5. Cheng J, et al. 2012. Mol Biol Cell. 23:2891. PubMed
  6. Vishwakarma V, et al. 2012. Infect Immun. 80:3236. PubMed
  7. Sun X, et al. 2013. J. Immunol. 190:2536. PubMed
  8. Van Phan T, et al. 2013. Biochem Pharmacol. 85:1145. PubMed
  9. Ranganathan P, et al. 2013. J Rhematol. 40:129. PubMed
  10. Din Su, et al. 2013. Occup Med. PubMed
  11. Bulut GB, et al. 2013. Blood. 122:3964. PubMed
  12. Chia YL, et al. 2013. Antiviral Res. 3542:354. PubMed
  13. Ahn JM, et al. 2014. Mol Cell Proteomics. 13:30. PubMed
  14. Din SU, et al. 2014. Occup Med. 64:39. PubMed
  15. Balmer ML, et al. 2014. Sci Transl Med. 21:237. PubMed
  16. Klehmet J, et al. 2014. J Neurol Neurosurg Psychiatry. PubMed
  17. Wu CC, et al. 2014. Cancer Epidemiol. Biomarkers Prev. 23:1569. PubMed
  18. Peng JG, et al. 2014. J Virol. 88:8386. PubMed
  19. Chlon TM, et al. 2014. J Virol. 88:11315. PubMed
  20. Sadovskaya I, et al. 2014. Carbohydr Poly. 111:139. PubMed
  21. Liu T, et al. 2015. Infect Immun. 83:2011. PubMed
  22. Himmelein S, et al. 2015. J Virol. 89:5747. PubMed
  23. Dinter J, et al. 2015. J Mol Endocrinol. 54:205. PubMed
  24. Yang L, et al. 2015. J Immunol. 194:5635. PubMed
Product Citations
  1. Cheng J, et al. 2012. Mol Biol Cell. 23:2891. PubMed
  2. Vishwakarma V, et al. 2012. Infect Immun . 80:3236. PubMed
  3. Sun X, et al. 2013. J Immunol. 190:2536. PubMed
  4. Phan T, et al. 2013. Biochem Pharmacol. 85:1145. PubMed
  5. Bulut G, et al. 2013. Blood. 122:3964. PubMed
  6. Chia Y, et al. 2013. Antiviral Res. 3542:354. PubMed
  7. Ahn J, et al. 2014. Mol Cell Proteomics. 13:30. PubMed
  8. Tidley S 2014. Occup Med. 64:39. PubMed
  9. Balmer M, et al. 2014. Sci Transl Med. 21:237. PubMed
  10. Klehmet J, et al. 2014. J Neurol Psychiatry. . PubMed
  11. Wu C, et al. 2014. Cancer Epidemiol Biomarkers Prev. 23:1569. PubMed
  12. Wu J 2014. J Virol. 88:8386. PubMed
  13. Chlon T, et al. 2014. J Virol. 88:11315. PubMed
  14. Sadovskaya I, et al. 2014. Carbohydr Polym. 111:139. PubMed
  15. Liu T, et al. 2015. Infect Immun . 83:2011. PubMed
  16. Himmelein S, et al. 2015. J Virol. 89:5747. PubMed
  17. Dinter J, et al. 2015. J Mol Endocrinol. 54:205. PubMed
  18. Shinohara M 2015. J Immunol. 194:5635. PubMed
  19. Zhang C, et al. 2015. J Surgical Res. 197: 301-306. PubMed
  20. Isernhagen A, et al. 2015. EMBO Mol Med. 7: 1480 - 1502. PubMed
  21. Hwang D, et al. 2016. PLoS One. 11: 0152522. PubMed
  22. Baerenwaldt A, et al. 2016. J Immunol. 196: 2561 - 2571. PubMed
  23. Parrish H, et al. 2016. Proc Natl Acad Sci U S A. 113: 3000 - 3005. PubMed
  24. Yen J, et al. 2015. J Leukoc Biol. 98: 689-702. PubMed
  25. Tu S, et al. 2015. Nature. 534:387-390. PubMed
  26. Czakai K, et al. 2016. Sci Rep. 6:27990. PubMed
  27. Morgan R, et al. 2016. PLoS One. 11: 0162008. PubMed
  28. Brugiroux S, et al. 2016. Nat Microbiol. 2:16215. PubMed
  29. Ye F, et al. 2016. J Virol. 90: 9654 - 9663. PubMed
  30. MÜller A, et al. 2016. PLoS One. 11:e0168260. PubMed
  31. Tsanov K, et al. 2016. Nat Cell Biol. 19:60-67. PubMed
  32. Gendron D, et al. 2017. Pulm Pharmacol Ther. 10.1016/j.pupt.2017.03.010. PubMed
  33. Counoupas C, et al. 2020. NPJ Vaccines. 0.28125. PubMed
  34. Xing QR, et al. 2020. Sci Adv. 6:00. PubMed
  35. Kim DJ, et al. 2020. Proc Natl Acad Sci U S A. 117:15837. PubMed
  36. Kiriakidis S, et al. 2017. Kidney International. 10.1016/j.kint.2017.03.008. PubMed
  37. Buschor S, et al. 2017. PLoS Pathogens. 13(6):e1006476. PubMed
  38. Hooper K, Kong W, Ganea D, et al. 2017. PLoS One. 12(6):e0179184. PubMed
  39. Tsukamoto H, et al. 2017. FEBS Lett. 10.1002/1873-3468.12768. PubMed
  40. Gröschel C, et al. 2017. Sci Rep.. 10.1038/s41598-017-16147-1. PubMed
  41. Peng Y 2017. PLoS One. 10.1371/journal.pone.0188112. PubMed
  42. Gröschel C, et al. 2018. Front Immunol. 9:2665. PubMed
  43. Wang YH, et al. 2018. Oncol Lett. 16:6903. PubMed
  44. Cárdenas–Torres FI, et al. 2019. Medicina (Kaunas). 55:3. PubMed
  45. Simic MS, et al. 2019. Sci Adv. 5:eaaw0025. PubMed
  46. Kikuchi N, et al. 2019. Biol Pharm Bull. 42:57. PubMed
  47. Gamache J, et al. 2019. Nat Commun. 10:2479. PubMed
  48. Duan S, et al. 2019. J Clin Invest. 129:1387. PubMed
  49. Nakanishi M, et al. 2019. Cell. 177:910. PubMed
  50. Crowley SJ, et al. 2020. Open Biol. 10:190235. PubMed
  51. Tuladhar R, et al. 2019. J Biol Chem. 294:6273. PubMed
  52. Herp S, et al. 2019. Cell Host Microbe. 25:681. PubMed
  53. den Hartigh AB, et al. 2018. Curr Protoc Immunol. :e52. PubMed
  54. Li K, et al. 2006. J Leukoc Biol . 80:350. PubMed
  55. Weldon S, et al. 2009. J Immunol. 183:8148. PubMed
  56. Basnayake K, et al. 2010. J Am Soc Nephrol. 1.684027778. PubMed
  57. Marder W, et al. 2011. Ann Rheum Dis. 70:1550. PubMed

Related FAQs

There are no FAQs for this product.
Go To Top Version: 5    Revision Date: 05-20-2020

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account